QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2018    内容类型：会议论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文 作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial 会议论文 作者:  Guo, Y.;  Luo, Y.;  Zhang, Q.;  Huang, X.;  Li, Z. 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05 A phase II randomized trial of gemcitabine plus cisplatin(GP) vs. gemcitabine plus carboplatin (GC) as the first-line treatment for patients with metastatic triple negative breast cancer 会议论文 作者:  Gong, Chengcheng;  Cao, Enying;  Wang, Zhonghua;  Zhang, Jian;  Wang, Leiping 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 Final results of a phase 3 study of comparing paclitaxel plus 5-fluorouracil versus cisplatin plus 5-fluorouracil in chemoradiotherapy for locally advanced esophageal carcinoma (ESO-Shanghai 1). 会议论文 作者:  Chen, Yun;  Ye, Jingjun;  Zhu, Zhengfei;  Zhao, Weixin;  Li, Ling 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05 Final Results of a Phase 3 Study of Comparing Paclitaxel Plus 5-Fluorouracil versus Cisplatin Plus 5-Fluorouracil in Chemoradiotherapy for Locally Advanced Esophageal Carcinoma 会议论文 作者:  Chen, Y.;  Ye, J.;  Zhu, Z.;  Zhao, W.;  Li, L. 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/05 CTONG 1103: Erlotinib versus gemcitabine plus cisplatin as neo-adjuvant treatment for stage IIIA-N2 EGFR-mutation non- small cell lung cancer (EMERGING): A randomised study 会议论文 作者:  Zhong, W-Z.;  Wu, Y-L.;  Chen, K-N.;  Chen, C.;  Gu, C-D. 收藏  |  浏览/下载：9/0  |  提交时间：2019/11/19 First-line cetuximab plus cisplatin and fluorouracil vs cisplatin and fluorouracil in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: The randomized, phase III CHANGE-2 trial 会议论文 ANNALS OF ONCOLOGY, 2018-11-01 作者:  Guo, Y.;  Luo, Y.;  Zhang, Q.;  Huang, X.;  Li, Z. 收藏  |  浏览/下载：4/0  |  提交时间：2020/01/03